AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionTRUE Private Wealth Advisors
Latest Disclosed Ownership27,103 shares
Latest Disclosed Value $ 5,894,695
TRUE Private Wealth Advisors reports 0.04% increase in ownership of 4AB / AbbVie Inc.

On May 15, 2026 - TRUE Private Wealth Advisors filed a 13F-HR form disclosing ownership of 27,103 shares of AbbVie Inc. (BG:4AB) valued at $5,894,695 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 27,092 shares of AbbVie Inc.. This represents a change in shares of 0.04% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE COM 00287Y109 27,103 11 0.04 5,895 -4.78 0.5619
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 27,092 82 0.30 6,190 -1.01 0.6202
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 27,010 384 1.44 6,254 26.53 0.6380
2025-08-11 2025-06-30 13F ABBVIE COM 00287Y109 26,626 -236 -0.88 4,942 -12.19 0.5553
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 26,862 -1,988 -6.89 5,628 9.79 0.6837
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 28,850 -370 -1.27 5,127 -11.16 0.6223
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 29,220 -323 -1.09 5,770 13.87 0.6884
2024-07-16 2024-06-30 13F ABBVIE COM 00287Y109 29,543 -1,975 -6.27 5,067 -11.71 0.5737
2024-04-25 2024-03-31 13F ABBVIE COM 00287Y109 31,518 -5,910 -15.79 5,739 -1.05 0.6583
2024-01-30 2023-12-31 13F ABBVIE COM 00287Y109 37,428 2,399 6.85 5,800 11.09 0.7341
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 35,029 1,572 4.70 5,221 15.84 0.7251
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 33,457 -302 -0.89 4,508 -16.23 0.6659
2023-05-11 2023-03-31 13F ABBVIE COM 00287Y109 33,759 530 1.59 5,380 0.19 0.7960
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 33,229 454 1.39 5,370 22.10 0.8270
2022-11-04 2022-09-30 13F ABBVIE INC COM COM 00287Y109 32,775 2,936 9.84 4,398 -3.76 0.6656
2022-07-28 2022-06-30 13F ABBVIE INC COM COM 00287Y109 29,839 585 2.00 4,570 3.07 0.6649
2022-05-09 2022-03-31 13F ABBVIE INC COM COM 00287Y109 29,254 -8,833 -23.19 4,434 -14.02 0.6239
2022-02-11 2021-12-31 13F ABBVIE INC COM COM 00287Y109 38,087 2,357 6.60 5,157 33.81 0.7339
2021-11-05 2021-09-30 13F AbbVie COM 00287Y109 35,730 -612 -1.68 3,854 -5.84 0.5609
2021-08-10 2021-06-30 13F AbbVie COM 00287Y109 36,342 1,368 3.91 4,093 8.14 0.6080
2021-05-12 2021-03-31 13F AbbVie COM 00287Y109 34,974 1,410 4.20 3,785 5.26 0.6117
2021-01-11 2020-12-31 13F AbbVie COM 00287Y109 33,564 -24 -0.07 3,596 22.23 0.6026
2020-10-09 2020-09-30 13F AbbVie COM 00287Y109 33,588 -566 -1.66 2,942 -12.26 0.5026
2020-07-07 2020-06-30 13F AbbVie COM 00287Y109 34,154 598 1.78 3,353 31.18 0.6134
2020-04-20 2020-03-31 13F AbbVie COM 00287Y109 33,556 28,475 560.42 2,556 469.27 0.5443
2020-01-27 2019-12-31 13F AbbVie COM 00287Y109 5,081 -448 -8.10 449 7.42 0.0688
2019-10-09 2019-09-30 13F AbbVie COM 00287Y109 5,529 1,127 25.60 418 30.63 0.0722
2019-08-01 2019-06-30 13F AbbVie COM 00287Y109 4,402 -30 -0.68 320 -10.36 0.0545
2019-04-25 2019-03-31 13F AbbVie COM 00287Y109 4,432 -1,749 -28.30 357 -37.26 0.0680
2019-01-14 2018-12-31 13F AbbVie COM 00287Y109 6,181 -5,325 -46.28 569 -99.95 0.1004
2018-10-18 2018-09-30 13F AbbVie COM 00287Y109 11,506 -690 -5.66 1,088,206 96,286.71 0.1531
2018-07-13 2018-06-30 13F AbbVie COM 00287Y109 12,196 2,339 23.73 1,129 21.01 0.1771
2018-04-25 2018-03-31 13F AbbVie COM 00287Y109 9,857 148 1.52 933 -0.64 0.1602
2018-01-19 2017-12-31 13F AbbVie COM 00287Y109 9,709 4,472 85.39 939 101.94 0.1627
2017-10-27 2017-09-30 13F AbbVie COM 00287Y109 5,237 423 8.79 465 33.24 0.1048
2017-08-07 2017-06-30 13F AbbVie COM 00287Y109 4,814 27 0.56 349 11.50 0.0809
2017-04-20 2017-03-31 13F AbbVie COM 00287Y109 4,787 24 0.50 313 7.93 0.0716
2017-02-14 2016-12-31 13F AbbVie COM 00287Y109 4,763 186 4.06 290 3.94 0.0708
2016-11-08 2016-09-30 13F AbbVie COM 00287Y109 4,577 13 0.28 279 -1.06 0.0895
2016-08-01 2016-06-30 13F AbbVie COM 00287Y109 4,564 799 21.22 282 31.16 0.0943
2016-06-16 2016-03-31 13F/A-1 AbbVie COM 00287Y109 3,765 3,765 215 0.0836
2016-05-11 2016-03-31 13F AbbVie COM 00287Y109 3,765 215 0.0836
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.